Clinical Trial Update: Flu Vaccine Response in Patients on Biologic Therapies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating flu vaccine response in patients receiving biologic therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Complex Diseases
• Inflammatory Bowel Diseases
• Rheumatologic Disorder

Snippet

Sponsor: Stony Brook University | Conditions: Rheumatologic Disorder, Inflammatory Bowel Diseases | Phase 2 | Status: COMPLETED